Open Access

Identification and analysis of survival‑associated ceRNA triplets in prostate adenocarcinoma

  • Authors:
    • Fan Li
    • Hai Li
    • Yi Hou
  • View Affiliations

  • Published online on: August 16, 2019     https://doi.org/10.3892/ol.2019.10752
  • Pages: 4040-4047
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prostate adenocarcinoma (PRAD) is one of the most common causes of cancer‑associated mortality worldwide. Recent evidence has emphasized the role of competitive endogenous RNAs (ceRNA) in prostate cancer. However, the current understanding of the roles that ceRNAs play in survival‑associated PRAD remains in its infancy. In the present study, a PRAD‑specific ceRNA network was constructed by integrating long non‑coding RNA (lncRNA)‑microRNA (miRNA)‑gene interactions using experimental and computational methods, as well as expression correlations from The Cancer Genome Atlas database. The topological features of the ceRNA network were then analyzed and the PRAD‑risk lncRNAs were compared with non‑risk lncRNAs within this network. It was revealed that PRAD‑risk lncRNAs had a higher degree, closeness and betweenness centrality, but also had the shortest path length. Finally, 42 significant PRAD‑survival‑associated triplets were identified. Notably, these triplets may form a compacted subnetwork composed of only 25 nodes (5 miRNAs, 4 lncRNAs and 16 genes) and 32 edges, indicating that some nodes were involved in many triplets. Among this subnetwork, mir‑21 indicated the highest degree centrality and was demonstrated to exert its oncogenic effects in prostate tumors by downregulating transforming growth factor β receptor 2 (TGFBR2). Two triplets (MIR22HG_hsa‑mir‑21_TGFBR2 and MIR22HG_hsa‑mir‑21_BCL2) were finally identified; not only were they significantly associated with PRAD survival but they also had the highest average degree in the identified subnetwork. The results from the present study provide further insights into the understanding of the potential roles and interactions of ceRNA triplets and potential prognosis markers for PRAD.

Related Articles

Journal Cover

October 2019
Volume 18 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, F., Li, H., & Hou, Y. (2019). Identification and analysis of survival‑associated ceRNA triplets in prostate adenocarcinoma. Oncology Letters, 18, 4040-4047. https://doi.org/10.3892/ol.2019.10752
MLA
Li, F., Li, H., Hou, Y."Identification and analysis of survival‑associated ceRNA triplets in prostate adenocarcinoma". Oncology Letters 18.4 (2019): 4040-4047.
Chicago
Li, F., Li, H., Hou, Y."Identification and analysis of survival‑associated ceRNA triplets in prostate adenocarcinoma". Oncology Letters 18, no. 4 (2019): 4040-4047. https://doi.org/10.3892/ol.2019.10752